Paloma Partners’s LifeMD LFMD Stock Holding History

Paloma Partners’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,976	Closed	-$161K	–	2006
2021 Q3	$161K	Buy	25,976 +3,228	+14%	+$27.5K	﹤0.01%	886
2021 Q2	$268K	Buy	+22,748	New	+$262K	﹤0.01%	1374

Other funds holding LFMD

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIA

Barry Investment Advisors New Bedford, Massachusetts $478M AUM 23.65% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Paloma Partners's LFMD Position: Q4 2021 in Review

Paloma Partners sold out of LifeMD (LFMD) in Q4 2021, closing a stake of 25,976 shares — an estimated $161K sold.

Paloma Partners first reported a position in LFMD in Q2 2021 and held it in 2 quarters. The position peaked at $268K in Q2 2021. 53 funds tracked by Wall St. Rank hold LFMD as of Q4 2021.

Paloma Partners reported no remaining LifeMD position as of Q4 2021 after selling out during the quarter.
Paloma Partners sold 25,976 LifeMD shares in Q4 2021, an estimated $161K.
Paloma Partners first reported a position in LifeMD in Q2 2021 and held it in 2 quarters.
Paloma Partners's LifeMD position peaked at $268K in Q2 2021.
53 funds tracked by Wall St. Rank held LifeMD as of Q4 2021.

Based on Paloma Partners's 13F filing for Q4 2021, filed 14 Feb 2022.